An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers

Published:1999 Issue:3 Volume:57 Page:202-210
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Sugimachi Keizo,Maehara Yoshihiko,Horikoshi Noboru,Shimada Yosuhiro,Sakata Yuh,Mitachi Yasushi,Taguchi Tetsuo

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii;International Journal of Clinical Oncology;2023-03-24

2. Phase I study of DFP-11207, a novel oral fluoropyrimidine with reasonable AUC and low Cmax and improved tolerability, in patients with solid tumors;Investigational New Drugs;2020-05-06

3. Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer;Radiotherapy and Oncology;2019-11

4. The optimal neoadjuvant treatment of locally advanced esophageal cancer;Journal of Thoracic Disease;2019-04

5. Elevated neutrophil‑to‑lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S‑1 plus cisplatin, and poor prognosis in patients with stage?IV gastric cancer;Molecular and Clinical Oncology;2017-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP